Indian API Manufacturer Cited for Investigative Deficiencies

Drug Industry Daily
A A
The FDA called out Indian API manufacturer Vamsi Labs for failing to complete investigations at its Solapur, Maharashtra facility, including one of API batches shipped to the U.S.

To View This Article:

Login

Subscribe To Drug Industry Daily